Shares of industrial gas giant Linde dropped Friday despite reporting better-than-expected profits and sales.
Linde remains a quiet beneficiary of the artificial intelligence boom, but problems facing part of its healthcare business are drowning out those benefits in the final trading session of the week
Our faith in Linde is unshaken, so Friday’s pullback looks more like a buying opportunity than a reason to head for the exits. Revenue in the second quarter ended June 30 rose 9.3% to $9.29 billion, surpassing the $8.99 billion consensus, according to LSEG. Adjusted earnings per share (EPS) totaled $4.50, beating the LSEG consensus by 2 cents and rising 10% year over year.
LIN YTD mountain Linde’s year-to-date stock performance. Linde shares slid more than 5.5% Friday, on pace for its worst day since the market’s tariff sell-off in April 2025. The stock entered Friday’s session down about 7% from its record close of $546.64 on July 2.